(Press-News.org) OAK BROOK, Ill. – Researchers have discovered that, compared to breast cancer that is symptom-detected, patients with breast cancer detected via routine screening mammography are more likely to have improved clinical outcomes, according to a study published today in Radiology: Imaging Cancer, a journal of the Radiological Society of North America (RSNA).
While it is commonly understood that early detection of breast cancer results in better patient outcomes, national cancer registries in the U.S. and Canada don’t track the method of cancer detection.
Since improvements in patient outcomes may be incorrectly attributed solely to treatment advances, identifying the association between the method of breast cancer detection and clinical outcomes may have a direct impact on health care policy.
“I observed a marked difference in the way breast cancers were being detected in my clinical practice,” said lead study author Jean M. Seely, M.D., F.R.C.P.C., a professor in the Department of Radiology at the University of Ottawa and head of the breast imaging section at Ottawa Hospital in Ontario, Canada. “I noted that many women under the age of 50 and older than 75 were diagnosed because of symptomatic presentation.”
In a retrospective observational analysis, Dr. Seely and colleagues collected data of patients aged 40 years or older who were diagnosed with breast cancer in 2016.
Of the 821 patients included in the study, 50.1% had breast cancer diagnosed as the result of a symptom, rather than as the result of a screening mammogram.
Compared to patients with symptom-detected breast cancer, patients with screening-detected breast cancer had significantly lower odds of an advanced stage of breast cancer, lower odds of undergoing a mastectomy and a lower hazard ratio of death.
Breast cancers detected from symptoms were more frequent in women aged 40 to 49 years and over 75 years of age, 72.9% and 70.4%, respectively. All-cause deaths were also higher among patients who were not undergoing regular screening. Most surprising was how many patients died shortly after their breast cancer was detected, Dr. Seely noted.
“Within only 6.7 years of follow-up, almost 20% of the 821 breast cancer patients had died, half of them from breast cancer,” Dr. Seely said. “The patients whose breast cancers were detected because of symptoms had a 63% higher likelihood of dying.”
The researchers concluded that reducing the barriers to breast cancer screening in women aged 40 to 74 will improve patient outcomes and reduce the number of patient deaths from cancer. Women over age 75 might also benefit from screening, as these patients were more likely to be diagnosed due to symptoms and required more intensive treatment.
In 2024, the United States Preventive Services Task Force (USPSTF) updated their breast cancer screening guidelines, recommending that women aged 40 to 75 years at average risk undergo breast cancer screening every two years. The Canadian Task Force on Preventive Health Care recommends that women aged 50 to 74 years at average risk undergo breast cancer screening every two to three years.
“The results of this study will likely support the move to reduce the breast cancer screening age to 40 in the U.S. and Canada,” Dr. Seely said. “We have lowered the screening age in many provincial and territorial screening programs in Canada and are aiming to establish a single national policy for screening.”
###
“Impact of Method of Detection of Breast Cancer on Clinical Outcomes in Individuals Aged 40 Years or Older.” Collaborating with Dr. Seely were Javeria Munir, M.D., Yashmin Nisha, M.B.B.S., Nayaar Islam, M.Sc., Mary Beth Bissell, M.D., F.R.C.P.C., Betty Anne Schwarz, D.Prof., M.Sc., and Erin Cordeiro, M.D., F.R.C.P.C.
Radiology: Imaging Cancer is edited by Gary D. Luker, M.D., Michigan Medicine, University of Michigan, Ann Arbor, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/journal/imaging-cancer)
RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Illinois. (RSNA.org)
For patient-friendly information on breast cancer screening, visit RadiologyInfo.org.
END
The number of people living with a history of cancer in the United States is estimated at 18.6 million as of January 1, 2025 and projected to exceed 22 million by 2035, according to a new report, Cancer Treatment and Survivorship Statistics, 2025, led by the American Cancer Society (ACS). The study also found notable disparities in treatment for many common cancers, including lung and colorectal. The findings are published today in CA: A Cancer Journal for Clinicians, alongside its consumer-friendly companion, Fast Facts: Cancer Treatment and Survivorship, available on cancer.org.
“Behind every survivor of ...
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by researchers at Washington University School of Medicine in St. Louis.
The clinical trial evaluated the safety and efficacy of an innovative CAR-T cell immunotherapy that is specifically designed to attack cancerous T cells. Participants in the trial had been diagnosed with rare cancers — T cell acute lymphoblastic leukemia or T cell lymphoblastic lymphoma — and had run out of treatment options after standard therapy proved ineffective for them. With the new immunotherapy, most of ...
A research team funded by the National Institutes of Health (NIH) has identified a diagnostic aid that has the potential to accurately predict the recurrence of diabetic foot ulcers that appear to be fully healed. By measuring the skin’s barrier function through a process known as trans-epidermal water loss, or TEWL, scientists were able to determine which wounds were more likely to reopen. TEWL measurements are a major factor in burn care, where deep layers of the skin are often damaged. The findings suggest that full restoration of skin ...
Complaint lines such as New York City’s 311 let people report quality-of-life problems in their building or neighborhood, from excessive noise to illegal parking. But resident-generated data typically suffer from reporting bias, with some neighborhoods and addresses calling attention to problems at lower rates than others.
A team of New York University researchers has developed an automated modeling tool to help the New York City government estimate 311 under-reporting by building, neighborhood, and subpopulation. In a new study, published today [May 30] in Annals of Applied Statistics, the researchers describe a method that, using machine learning, can estimate the potential ...
May 30, 2025 — A proposed classification system appears highly accurate in evaluating nasal deformities in infants with cleft lip and/or palate (CLP), reports a study in the May/June issue of The Journal of Craniofacial Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer.
"This new tool offers a reliable and practice tool for categorizing the severity of nasal deformities in CLP patients," comments lead author Martha Mejia, DDS, of Nicklaus Children's Health System, Miami. "With ongoing evaluation, it may promote more consistent diagnosis, individualized treatment planning, and standardized approaches ...
Background and objectives
This study investigates upper gastrointestinal tract (UGIT) involvement in patients with ulcerative colitis (UC), a condition traditionally considered limited to the colon. Although extra-colonic manifestations of UC are well recognized, UGIT issues have received less attention. This research aimed to document the clinical, endoscopic, and histopathological UGIT findings in adults with UC and assess their association with disease severity and extent.
Methods
This descriptive cross-sectional study was conducted at Ain Shams University over one year. A total of 78 UC patients underwent comprehensive clinical evaluations, including assessments ...
Approximately 8 to 12% of patients with colorectal cancer have BRAF mutations
Treatment with the triplet combination of drugs – encorafenib, cetuximab and chemotherapy – helped patients live longer and kept cancer from progressing
The Food and Drug Administration granted accelerated approval for this new combination in Dec. 2024
Median overall survival was 30.3 months with the triplet therapy, compared to 15.1 months with standard treatment
ABSTRACT: ...
Once organizations achieve their profitability and market performance targets, they often focus on additional goals. However, these goals do not always align and can sometimes conflict. For example, prioritizing shareholder returns may come at the expense of investments in social causes. This raises a critical question: How do companies decide where to allocate their surplus resources and which goals to prioritize?
A study published online in the Journal of Business Ethics on May 9, 2025, examines this question by turning the spotlight on the boardroom. A research team consisting of Professor Toru Yoshikawa from the School of Social Sciences, Waseda University, ...
Autism spectrum disorders are associated with difficulties in social communication, long attributed to individual socio-cognitive deficits. As a consequence of this perspective, stigma and pressure to conform to neurotypical social norms often lead to mental health challenges among autistic individuals. Emerging theories suggest that communication difficulties may rather arise from mismatches in perspectives between autistic and non-autistic partners. Addressing this mismatch collaboratively could transform the understanding of autism and improve communication outcomes.
Social behavior also varies significantly across cultures. ...
Resistance to disease should mean a longer life, but researchers have found that a mutant protein that helps a plant fight mildew might make it age sooner.
The Osaka Metropolitan University research team of Graduate School of Agriculture student Tomoko Matsumoto and Professor Noriko Inada and Graduate School of Science Professor Koichi Kobayashi discovered that thale cress (Arabidopsis thaliana) plants with the mutant Actin Depolymerizing Factor protein turn yellow sooner over time and in dark conditions compared to wild-type thale cress.
“ADFs are involved not only in leaf aging ...
